The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
The Endocrine Disruptor Monoethyl-hexyl-phthalate Is a Selective Peroxisome Proliferator-activated Receptor γ Modulator That Promotes Adipogenesis
Open accessAbstract
The ability of pollutants to affect human health is a major concern, justified by the wide demonstration that reproductive functions are altered by endocrine disrupting chemicals. The definition of endocrine disruption is today extended to broader endocrine regulations, and includes activation of metabolic sensors, such as the peroxisome proliferator-activated receptors (PPARs). Toxicology approaches have demonstrated that phthalate plasticizers can directly influence PPAR activity. What is now missing is a detailed molecular understanding of the fundamental basis of endocrine disrupting chemical interference with PPAR signaling. We thus performed structural and functional analyses that demonstrate how monoethyl-hexyl-phthalate (MEHP) directly activates PPARgamma and promotes adipogenesis, albeit to a lower extent than the full agonist rosiglitazone. Importantly, we demonstrate that MEHP induces a selective activation of different PPARgamma target genes. Chromatin immunoprecipitation and fluorescence microscopy in living cells reveal that this selective activity correlates with the recruitment of a specific subset of PPARgamma coregulators that includes Med1 and PGC-1alpha, but not p300 and SRC-1. These results highlight some key mechanisms in metabolic disruption but are also instrumental in the context of selective PPAR modulation, a promising field for new therapeutic development based on PPAR modulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins
MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., Fischer, S., Gao, J., Guo, H., Ha, S., et al. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp973084f · Cited by 14,311
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94
Halgren, T. A. (1996) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(199604)17:5/6<490::aid-jcc1>3.0.co;2-p · Cited by 5,306
Hellemans, J., Mortier, G., De Paepe, A., Speleman, F., & Vandesompele, J. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r19 · Cited by 4,023
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
Yang, Y. H. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.4.e15 · Cited by 3,464
Berman, H. M., Battistuz, T., Bhat, T. N., Bluhm, W. F., Bourne, P. E., Burkhardt, K., Feng, Z., Gilliland, G. L., Iype, L., Jain, S., et al. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902003451 · Cited by 2,577
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., & Milburn, M. V. (1998) · Nature · doi:10.1038/25931 · Cited by 1,958
Normalization of cDNA microarray data
Smyth, G. K., & Speed, T. (2003) · Methods · doi:10.1016/s1046-2023(03)00155-5 · Cited by 1,871
PPARs and the complex journey to obesity
Evans, R. M., Barish, G. D., & Wang, Y.-X. (2004) · Nature Medicine · doi:10.1038/nm1025 · Cited by 1,602
Lehrke, M., & Lazar, M. A. (2005) · Cell · doi:10.1016/j.cell.2005.11.026 · Cited by 1,443
Métivier, R., Penot, G., Hübner, M. R., Reid, G., Brand, H., Koš, M., & Gannon, F. (2003) · Cell · doi:10.1016/s0092-8674(03)00934-6 · Cited by 1,431
Self-citationFeige, J. N., Gelman, L., Michalik, L., Desvergne, B., & Wahli, W. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.12.002 · Cited by 786
Self-citationPPARs: therapeutic targets for metabolic disease
Berger, J. P., Akiyama, T. E., & Meinke, P. T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.003 · Cited by 713
Endocrine-Disrupting Organotin Compounds Are Potent Inducers of Adipogenesis in Vertebrates
Grün, F., Watanabe, H., Zamanian, Z., Maeda, L., Arima, K., Cubacha, R., Gardiner, D. M., Kanno, J., Iguchi, T., & Blumberg, B. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0367 · Cited by 612
Activation of PPAR and PPAR by Environmental Phthalate Monoesters
Hurst, C. H., & Waxman, D. J. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg145 · Cited by 510
Lee, M. S., Feig, M., Salsbury, F. R., & Brooks, C. L. (2003) · Journal of Computational Chemistry · doi:10.1002/jcc.10272 · Cited by 504
New Modes of Action for Endocrine-Disrupting Chemicals
Tabb, M. M., & Blumberg, B. (2006) · Molecular Endocrinology · doi:10.1210/me.2004-0513 · Cited by 449
trans-Activation of PPARα and PPARγ by Structurally Diverse Environmental Chemicals
Maloney, E. K., & Waxman, D. J. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8809 · Cited by 374
Kanayama, T., Kobayashi, N., Mamiya, S., Nakanishi, T., & Nishikawa, J.-I. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008409 · Cited by 354
Cronet, P., Petersen, J. F. W., Folmer, R., Blomberg, N., Sjöblom, K., Karlsson, U., Lindstedt, E.-L., & Bamberg, K. (2001) · Structure · doi:10.1016/s0969-2126(01)00634-7 · Cited by 325
Berger, J. P., Petro, A. E., Macnaul, K. L., Kelly, L. J., Zhang, B. B., Richards, K., Elbrecht, A., Johnson, B. A., Zhou, G., Doebber, T. W., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0217 · Cited by 321
Transcription coactivator TRAP220 is required for PPARγ2-stimulated adipogenesis
Ge, K., Guermah, M., Yuan, C.-X., Ito, M., Wallberg, A. E., Spiegelman, B. M., & Roeder, R. G. (2002) · Nature · doi:10.1038/417563a · Cited by 319
Huber, W. W., Grasl-kraupp, B., & Schulte-hermann, R. (1996) · Critical Reviews in Toxicology · doi:10.3109/10408449609048302 · Cited by 302
Modes of Action and Species-Specific Effects of Di-(2-ethylhexyl)Phthalate in the Liver
Rusyn, I., Peters, J. M., & Cunningham, M. L. (2006) · Critical Reviews in Toxicology · doi:10.1080/10408440600779065 · Cited by 301
Corepressors selectively control the transcriptional activity of PPARγ in adipocytes
Guan, H.-P., Ishizuka, T., Chui, P. C., Lehrke, M., & Lazar, M. A. (2005) · Genes & Development · doi:10.1101/gad.1263305 · Cited by 293
Schupp, M., Clemenz, M., Gineste, R., Witt, H., Janke, J., Helleboid, S., Hennuyer, N., Ruiz, P., Unger, T., Staels, B., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3442 · Cited by 274
A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic Activity
Rocchi, S., Picard, F., Vamecq, J., Gelman, L., Potier, N., Zeyer, D., Dubuquoy, L., Bac, P., Champy, M.-F., Plunket, K. D., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00353-7 · Cited by 272
Self-citationEndocrine disrupters: A human risk?
Waring, R. H., & Harris, R. M. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.02.007 · Cited by 239
Yu, C., Markan, K., Temple, K. A., Deplewski, D., Brady, M. J., & Cohen, R. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409468200 · Cited by 238
Bility, M. T. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh253 · Cited by 231
Gelman, L., Zhou, G., Fajas, L., Raspé, E., Fruchart, J.-C., & Auwerx, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7681 · Cited by 223
Self-citationBe Fit or Be Sick: Peroxisome Proliferator-Activated Receptors Are Down the Road
Desvergne, B., Michalik, L., & Wahli, W. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0088 · Cited by 222
Self-citationFeige, J. N., Sage, D., Wahli, W., Desvergne, B., & Gelman, L. (2005) · Microscopy Research and Technique · doi:10.1002/jemt.20215 · Cited by 215
Self-citationEndocrine disruptors: from Wingspread to environmental developmental biology
Markey, C. M., Rubin, B. S., Soto, A. M., & Sonnenschein, C. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00272-8 · Cited by 212
Nadra, K., Anghel, S. I., Joye, E., Tan, N. S., Basu-Modak, S., Trono, D., Wahli, W., & Desvergne, B. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3266-3281.2006 · Cited by 198
Self-citationPPARγ regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1
Chui, P. C., Guan, H.-P., Lehrke, M., & Lazar, M. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24130 · Cited by 178
Role of PPARα in mediating the effects of phthalates and metabolites in the liver
Lapinskas, P. J., Brown, S., Leesnitzer, L. M., Blanchard, S., Swanson, C., Cattley, R. C., & Corton, J. C. (2005) · Toxicology · doi:10.1016/j.tox.2004.09.008 · Cited by 173
Burgermeister, E., Schnoebelen, A., Flament, A., Benz, J., Stihle, M., Gsell, B., Rufer, A., Ruf, A., Kuhn, B., Märki, H. P., et al. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0171 · Cited by 160
Feige, J. N., Gelman, L., Tudor, C., Engelborghs, Y., Wahli, W., & Desvergne, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500786200 · Cited by 137
Self-citationHenley, D. V., & Korach, K. S. (2006) · Endocrinology · doi:10.1210/en.2005-1117 · Cited by 133
Takeuchi, S., Matsuda, T., Kobayashi, S., Takahashi, T., & Kojima, H. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.08.011 · Cited by 100
Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614
Minoura, H., Takeshita, S., Ita, M., Hirosumi, J., Mabuchi, M., Kawamura, I., Nakajima, S., Nakayama, O., Kayakiri, H., Oku, T., et al. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.04.038 · Cited by 79
Shi, G. Q., Dropinski, J. F., McKeever, B. M., Xu, S., Becker, J. W., Berger, J. P., MacNaul, K. L., Elbrecht, A., Zhou, G., Doebber, T. W., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0502135 · Cited by 79
Selective Modulators of PPAR Activity as New Therapeutic Tools in Metabolic Diseases
Bálint, B. L., & Nagy, L. T. (2006) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153006776056620 · Cited by 74
Rodent Carcinogenicity of Peroxisome Proliferators and Issues on Human Relevance
Lai, D. Y. (2004) · Journal of Environmental Science and Health Part C · doi:10.1081/gnc-120038005 · Cited by 51
Jeannin, E., Robyr, D., & Desvergne, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24239 · Cited by 51
Self-citationTudor, C., Feige, J. N., Pingali, H., Lohray, V. B., Wahli, W., Desvergne, B., Engelborghs, Y., & Gelman, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608172200 · Cited by 47
Self-citationFujimura, T., Sakuma, H., Konishi, S., Oe, T., Hosogai, N., Kimura, C., Aramori, I., & Mutoh, S. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050578 · Cited by 39
Michalik, L., Zoete, V., Krey, G. D., Grosdidier, A., Gelman, L., Chodanowski, P., Feige, J. N., Desvergne, B., Wahli, W., & Michielin, O. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610523200 · Cited by 37
Self-citationFujimura, T., Kimura, C., Oe, T., Takata, Y., Sakuma, H., Aramori, I., & Mutoh, S. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102459 · Cited by 35
Cited by
Endocrine Disruptors: From Endocrine to Metabolic Disruption
Casals-Casas, C., & Desvergne, B. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142200 · Cited by 902
Self-citationEndocrine disrupters as obesogens
Grün, F., & Blumberg, B. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.018 · Cited by 582
Endocrine disruptors and obesity
Heindel, J. J., Newbold, R., & Schug, T. T. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.163 · Cited by 451
Hatch, E. E., Nelson, J. W., Qureshi, M. M., Weinberg, J., Moore, L. L., Singer, M., & Webster, T. F. (2008) · Environmental Health · doi:10.1186/1476-069x-7-27 · Cited by 436
Endocrine Disruptors and Obesity
Darbre, P. D. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0240-4 · Cited by 395
Metadata
- Authors
- Feige, J. N., Gelman, L., Rossi, D., Zoete, V., Métivier, R., Tudor, C., Anghel, S. I., Grosdidier, A., Lathion, C., Engelborghs, Y., Michielin, O., Wahli, W., & Desvergne, B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 282
- Issue
- 26
- Pages
- 19152-19166
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2056250382
- Cited by
- 356
- References
- 52
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.